State Street’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $136M | Buy |
1,818,186
+45,288
| +3% | +$2.91M | ﹤0.01% | 1298 |
|
|
2026
Q1 | $99.9M | Buy |
1,772,898
+43,051
| +2% | +$2.8M | ﹤0.01% | 1371 |
|
|
2025
Q4 | $139M | Sell |
1,729,847
-70,882
| -4% | -$4.76M | ﹤0.01% | 1169 |
|
|
2025
Q3 | $87.8M | Sell |
1,800,729
-83,254
| -4% | -$5.15M | ﹤0.01% | 1406 |
|
|
2025
Q2 | $141M | Sell |
1,883,983
-34,033
| -2% | -$2.25M | 0.01% | 1126 |
|
|
2025
Q1 | $122M | Sell |
1,918,016
-28,971
| -1% | -$1.97M | 0.01% | 1169 |
|
|
2024
Q4 | $152M | Buy |
1,946,987
+58,494
| +3% | +$4.7M | 0.01% | 1092 |
|
|
2024
Q3 | $152M | Buy |
1,888,493
+38,010
| +2% | +$3.07M | 0.01% | 1089 |
|
|
2024
Q2 | $153M | Buy |
1,850,483
+18,313
| +1% | +$1.61M | 0.01% | 1023 |
|
|
2024
Q1 | $156M | Buy |
1,832,170
+42,534
| +2% | +$3.34M | 0.01% | 1021 |
|
|
2023
Q4 | $153M | Buy |
1,789,636
+48,151
| +3% | +$4.16M | 0.01% | 1016 |
|
|
2023
Q3 | $156M | Sell |
1,741,485
-12,348
| -0.7% | -$1.1M | 0.01% | 902 |
|
|
2023
Q2 | $149M | Buy |
1,753,833
+19,053
| +1% | +$1.61M | 0.01% | 973 |
|
|
2023
Q1 | $144M | Buy |
1,734,780
+42,985
| +3% | +$3.48M | 0.01% | 965 |
|
|
2022
Q4 | $133M | Sell |
1,691,795
-5,389
| -0.3% | -$433K | 0.01% | 989 |
|
|
2022
Q3 | $126M | Buy |
1,697,184
+27,667
| +2% | +$1.99M | 0.01% | 975 |
|
|
2022
Q2 | $109M | Sell |
1,669,517
-65,072
| -4% | -$3.85M | 0.01% | 1092 |
|
|
2022
Q1 | $110M | Buy |
1,734,589
+43,396
| +3% | +$2.36M | 0.01% | 1227 |
|
|
2021
Q4 | $89.7M | Buy |
1,691,193
+29,958
| +2% | +$1.83M | ﹤0.01% | 1383 |
|
|
2021
Q3 | $117M | Sell |
1,661,235
-13,719
| -0.8% | -$866K | 0.01% | 1144 |
|
|
2021
Q2 | $112M | Buy |
1,674,954
+447,875
| +36% | +$31.7M | 0.01% | 1214 |
|
|
2021
Q1 | $136M | Buy |
1,227,079
+5,826
| +0.5% | +$721K | 0.01% | 1004 |
|
|
2020
Q4 | $145M | Sell |
1,221,253
-1,016
| -0.1% | -$109K | 0.01% | 901 |
|
|
2020
Q3 | $107M | Sell |
1,222,269
-37,953
| -3% | -$3.32M | 0.01% | 931 |
|
|
2020
Q2 | $113M | Sell |
1,260,222
-414,668
| -25% | -$41.9M | 0.01% | 880 |
|
|
2020
Q1 | $167M | Buy |
1,674,890
+22,624
| +1% | +$2.45M | 0.01% | 669 |
|
|
2019
Q4 | $190M | Sell |
1,652,266
-30,216
| -2% | -$3.66M | 0.01% | 724 |
|
|
2019
Q3 | $212M | Sell |
1,682,482
-40,900
| -2% | -$5.19M | 0.02% | 668 |
|
|
2019
Q2 | $207M | Buy |
1,723,382
+1,715
| +0.1% | +$169K | 0.02% | 682 |
|
|
2019
Q1 | $151M | Buy |
1,721,667
+62,609
| +4% | +$5.69M | 0.01% | 777 |
|
|
2018
Q4 | $166M | Sell |
1,659,058
-186,003
| -10% | -$19.5M | 0.02% | 684 |
|
|
2018
Q3 | $211M | Buy |
1,845,061
+31,634
| +2% | +$3.27M | 0.02% | 689 |
|
|
2018
Q2 | $163M | Buy |
1,813,427
+410,039
| +29% | +$34.6M | 0.01% | 772 |
|
|
2018
Q1 | $103M | Buy |
1,403,388
+5,877
| +0.4% | +$403K | 0.01% | 986 |
|
|
2017
Q4 | $81.2M | Buy |
1,397,511
+63,653
| +5% | +$3.35M | 0.01% | 1141 |
|
|
2017
Q3 | $59.9M | Buy |
1,333,858
+2,864
| +0.2% | +$119K | 0.01% | 1264 |
|
|
2017
Q2 | $52.6M | Buy |
1,330,994
+62,887
| +5% | +$2.58M | ﹤0.01% | 1326 |
|
|
2017
Q1 | $51.4M | Buy |
1,268,107
+97,466
| +8% | +$3.81M | ﹤0.01% | 1314 |
|
|
2016
Q4 | $47.1M | Buy |
1,170,641
+86,552
| +8% | +$3.26M | ﹤0.01% | 1303 |
|
|
2016
Q3 | $39.3M | Buy |
1,084,089
+64,873
| +6% | +$2.23M | ﹤0.01% | 1349 |
|
|
2016
Q2 | $29.5M | Sell |
1,019,216
-11,178
| -1% | -$338K | ﹤0.01% | 1480 |
|
|
2016
Q1 | $36M | Buy |
1,030,394
+11,371
| +1% | +$367K | ﹤0.01% | 1331 |
|
|
2015
Q4 | $32.9M | Buy |
1,019,023
+22,859
| +2% | +$741K | ﹤0.01% | 1397 |
|
|
2015
Q3 | $32.2M | Sell |
996,164
-90,871
| -8% | -$3.42M | ﹤0.01% | 1425 |
|
|
2015
Q2 | $45M | Sell |
1,087,035
-49,003
| -4% | -$2.07M | ﹤0.01% | 1334 |
|
|
2015
Q1 | $51M | Sell |
1,136,038
-1,725
| -0.2% | -$72.1K | 0.01% | 1228 |
|
|
2014
Q4 | $42.6M | Sell |
1,137,763
-7,098
| -0.6% | -$260K | ﹤0.01% | 1311 |
|
|
2014
Q3 | $40M | Sell |
1,144,861
-25,387
| -2% | -$906K | ﹤0.01% | 1291 |
|
|
2014
Q2 | $41.3M | Sell |
1,170,248
-8,834
| -0.7% | -$295K | ﹤0.01% | 1320 |
|
|
2014
Q1 | $38.4M | Buy |
1,179,082
+12,859
| +1% | +$491K | ﹤0.01% | 1357 |
|
|
2013
Q4 | $49.1M | Sell |
1,166,223
-9,841
| -0.8% | -$405K | 0.01% | 1202 |
|
|
2013
Q3 | $46.9M | Buy |
1,176,064
+1,606
| +0.1% | +$67.4K | 0.01% | 1200 |
|
|
2013
Q2 | $48.6M | Buy |
+1,174,458
| New | +$47.5M | 0.01% | 1132 |
|
Other funds holding HAE
AI
RRAM
State Street's HAE Position: Q2 2026 in Review
State Street increased its Haemonetics (HAE) stake by 2.6% in Q2 2026, buying an estimated $2.91M and bringing the position to 1,818,186 shares worth $136M. The position accounts for ﹤0.01% of the portfolio, ranked #1298.
State Street first reported a position in HAE in Q2 2013 and has held it in 53 quarters since. The position peaked at $212M in Q3 2019. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.
- State Street held 1,818,186 shares of Haemonetics worth $136M as of Q2 2026.
- State Street bought 45,288 Haemonetics shares in Q2 2026, an estimated $2.91M.
- Haemonetics made up ﹤0.01% of State Street's portfolio in Q2 2026, its #1298 holding.
- State Street first reported a position in Haemonetics in Q2 2013 and has held it in 53 quarters since.
- State Street's Haemonetics position peaked at $212M in Q3 2019.
- 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.
Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.